» Articles » PMID: 32336590

Long Non-coding RNA MALAT1 Aggravates Human Retinoblastoma by Sponging MiR-20b-5p to Upregulate STAT3

Overview
Specialty Pathology
Date 2020 Apr 28
PMID 32336590
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Retinoblastoma (RB) is an uncommon childhood carcinoma of the developing retina. Long non-coding RNA (lncRNA) metastasis associated lung adenocarcinoma transcript 1 (MALAT1), microRNA-20b-5p (miR-20b-5p) and signal transducer and activator of transcription 3 (STAT3) was revealed to partake in RB. But their relationship was still to be investigated, so we intended to discuss the specific interaction of MALAT1, miR-20b-5p and STAT3 in RB.

Methods: By RNA isolation and quantitation, we measured the MALAT1 expression in RB tissues and cell lines. Then, to determine the influence of MALAT1 on RB cells, RB cells were transfected with siRNA-MALAT1 or pcDNA-MALAT1. The interplay among MALAT1, miR-20b-5p and STAT3 were evaluated through dual luciferase reporter gene assay and RNA pull-down after RB cells treated with siRNA/pcDNA-MALAT1 or/and miR-20b-5p mimic/inhibitor. The influence of their interaction on cells was evaluated by cell counting kit-8, EdU assay and flow cytometry. Finally, the involvement of MALAT1 in tumorigenesis was elucidated in vivo.

Results: Both RB tissues and cells showed highly expressed MALAT1. When MALAT1 was downregulated, RB cell proliferation was hindered and apoptosis was accelerated. MALAT1 sponged miR-20b-5p and upregulated STAT3. Silencing MALAT1 or overexpressing miR-20b-5p inhibited proliferation and promoted apoptosis in RB cells. The tumor growth of nude mice treated with siRNA-MALAT1 was inhibited.

Conclusion: MALAT1 could increase proliferation and reduce apoptosis by sponging miR-20b-5p to upregulate STAT3 in RB cells. Therefore, MALAT1 might be a latent target in the RB treatment.

Citing Articles

Possible Role of Endothelial-Derived Cellular and Exosomal-miRNAs in Lipid-Mediated Diabetic Retinopathy: Microarray Studies.

Elmasry K, Habib S, Helwa I, Khaled M, Ibrahim A, Tawfik A Cells. 2024; 13(22).

PMID: 39594634 PMC: 11592818. DOI: 10.3390/cells13221886.


Potential roles of lncRNA MALAT1-miRNA interactions in ocular diseases.

Nasrolahi A, Pour F, Salehi A, Kempisty B, Hajizadeh M, Feghhi M J Cell Commun Signal. 2023; 17(4):1203-1217.

PMID: 37870615 PMC: 10713964. DOI: 10.1007/s12079-023-00787-2.


Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression.

Ahangar Davoodi N, Najafi S, Ghale-Noie Z, Piranviseh A, Mollazadeh S, Ahmadi Asouri S Front Cell Dev Biol. 2023; 10:1065837.

PMID: 36619866 PMC: 9816416. DOI: 10.3389/fcell.2022.1065837.


Risk of secondary tumours in patients with non-metastatic and metastatic human retinoblastoma.

Sadeghi R, Pirankuraim H, Javanshir S, Arabi M, Bereimipour A, Javanshir H Eye (Lond). 2022; 37(11):2327-2334.

PMID: 36528757 PMC: 10366135. DOI: 10.1038/s41433-022-02345-3.


The long noncoding RNA MALAT1/microRNA-598-3p axis regulates the proliferation and apoptosis of retinoblastoma cells through the PI3K/AKT pathway.

Lin X, Huang X, Wang L, Liu W Mol Vis. 2022; 28:269-279.

PMID: 36284668 PMC: 9514550.